In the lab, our scientists develop new ways to detect, surveil, intercept, and treat BRCA related and other hereditary cancers.
While much has been accomplished in the clinical and research communities to understand the impact of BRCA pathogenic variants, there is more work to be done. At the Center for BRCA Research, some of our work includes:
- Developing a new blood test that would be the first early-detection tool for ovarian cancer.
- Developing an understanding of the risk for cancers such as pancreatic, prostate and melanoma in people with BRCA.
- Creating drug delivering implants that can prevent or treat breast or prostate cancer locally, eliminating the need for high-risk surgeries.
- Developing an understanding of what may affect/impact cancer risk.
- Applying precision medicine to personalize treatments for patients by offering tailored drugs and drug combinations for greater effectiveness.
- Discovering new strategies to find and treat drug-resistant BRCA tumors.
- Screening large populations to identify individuals in communities known to have high rates of the BRCA pathogenic variant, as well as diverse populations that are commonly overlooked.
